Anterior cerebral artery emboli in combined intravenous and intra-arterial rtPA treatment of acute ischemic stroke in the IMS I and II trials

American Journal of Neuroradiology

Volumn 28, Issue 10, 2007, Pages 1890-1894

  King, S ^a   Khatri, P ^a   Carrozella, J ^a   Spilker, J ^a   Broderick, J ^a   Hill, M ^a   Tomsick, Thomas ^a,b  

^a UNIVERSITY OF CINCINNATI   (United States)

^b UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE;

ACUTE DISEASE; ARTERIOGRAPHY; ARTICLE; BLOOD CLOT LYSIS; CEREBROVASCULAR ACCIDENT; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FIBRINOLYSIS; HUMAN; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; OCCLUSIVE CEREBROVASCULAR DISEASE; PREVALENCE;

ANTERIOR CEREBRAL ARTERY; CEREBRAL ANGIOGRAPHY; CEREBRAL INFARCTION; CLINICAL TRIALS AS TOPIC; HUMANS; INJECTIONS, INTRA-ARTERIAL; INTRACRANIAL EMBOLISM; RECOMBINANT PROTEINS; STROKE; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR; TOMOGRAPHY, X-RAY COMPUTED;

EID: 36448936376     PISSN: 01956108     EISSN: None     Source Type: Journal    
DOI: 10.3174/ajnr.A0702     Document Type: Article

References (31)

1. Qureshi AI, Siddiqui AM, Suri MF, et al. Aggressive mechanical clot disruption and low-dose intra-arterial third-generation thrombolytic agent for ischemic stroke: a prospective study. Neurosurgery 2002;51:1319-27; discussion 1327-29
2. IMS Study Investigators. Combined intravenous and intra-arterial recanalization for acute ischemic stroke: the Interventional Management of Stroke Study. Stroke 2004;35:904-11
3. IMS II trial investigators. The International Management of Stroke (IMS) II study. Stroke 2007;38:2127-35
4. Mahon BR, Nesbit GM, Barnwell SL, et al. North American clinical experience with the EKOS MicroLysUS infusion catheter for the treatment of embolic stroke. AJNR Am J Neuroradiol 2003;24:534-38
5. Higashida RT, Furlan AJ, Roberts H, et al. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke [published erratum appears in Stroke 2003;34:2774]. Stroke 2003;34:e109-37
6. Khatri P, Neff J, Broderick JP, et al. Revascularization end points in stroke interventional trials: recanalization versus reperfusion in IMS-I. Stroke 2005;36:2400-03
7. Furlan A, Higashida R, Wechsler L, et al. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA 1999;282:2003-11
8. Smith WS, Sung G, Starkman S, et al. Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial. Stroke 2005;36:1432-38
9. Nakano S, Yokogami K, Ohta H, et al. Direct percutaneous transluminal an gioplasty for acute middle cerebral artery occlusion. AJNR Am J Neuroradiol 1998;19:767-72
10. Nakano S, Yokogami K, Ohta H, et al. Direct percutaneous transluminal angioplasty for acute middle cerebral artery occlusion: report of two cases. Angiology 1997;6:254-56
11. Purdy PD, Devous MD, Unwin DH, et al. Angioplasty of an atherosclerotic middle cerebral artery associated with improvement in regional cerebral blood flow. AJNR Am J Neuroradiol 1990;11:878-80
12. Ringer AJ, Qureshi AI, Fessler RD, et al. Angioplasty of intracranial occlusion resistant to thrombolysis in acute ischemic stroke. Neurosurgery 2001;48:1282-88; discussion 1288-90
13. Tsai FY, Berberian B, Matovich V, et al. Percutaneous transluminal angioplasty adjunct to thrombolysis for acute middle cerebral artery rethrombosis. AJNR Am J Neuroradiol 1994;15:1823-29
14. Nakano S, Iseda T, Yoneyama T, et al. Intravenous low-dose native tissue plasminogen activator for distal embolism in the middle cerebral artery divisions or branches: a pilot study. Neurosurgery 2000;46:853-58; discussion 858-59
15. Yoneyama T, Sakano S, Kawano H, et al. Combined direct percutaneous transluminal angioplasty and low-dose native tissue plasminogen activator therapy for acute embolic middle cerebral artery trunk occlusion. AJNR Am J Neuroradiol 2002;23:277-81
16. Barnwell SL, Clark WM, Nguyen TT, et al. Safety and efficacy of delayed intraarterial urokinase therapy with mechanical clot disruption for thromboembolic stroke. AJNR Am J Neuroradiol 1994;15:1817-22
17. Noser EA, Shaltoni HM, Hall CE, et al. Aggressive mechanical clot disruption: a safe adjunct to thrombolytic therapy in acute stroke? Stroke 2005;36:292-96
18. Arnold M, Nedeltchev K, Mattle HP, et al. Intra-arterial thrombolysis in 24 consecutive patients with internal carotid artery T occlusions. J Neurol Neurosurg Psychiatry 2003;74:739-42
19. Zaidat OO, Suarez JI, Santillan C, et al. Response to intra-arterial and combined intravenous and intra-arterial thrombolytic therapy in patients with distal internal carotid artery occlusion. Stroke 2002;33:1821-26
20. Christoforidis GA, Mohammad Y, Kehagias D, et al. Angiographic assessment of pial collaterals as a prognostic indicator following intra-arterial thrombolysis for acute ischemic stroke. AJNR Am J Neuroradiol 2005;26:1789-97
21. Mori E, Tabuchi M, Yoshida T, et al. Intracarotid urokinase with thromboembolic occlusion of the middle cerebral artery. Stroke 1988;19:802-12
22. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med 1995;333:1581-87
23. Wardlaw JM, Warlow CP, Counsell C. Systemic review of evidence on thrombolytic therapy for acute ischaemic stroke. Lancet 1997;350:607-14
24. Gönner F, Remonda L, Mattle, H, et al. Local intra-arterial thrombolysis in acute ischemic stroke. Stroke 1998;29:1894-900
25. Donnan GA, Davis SM, Chambers BR, et al. Streptokinase in acute ischemic stroke with relationship to time of administration: Australian Streptokinase (ASK) Trial Study Group. JAMA 1996;276:961-66
26. von Kummer R, Holle R, Rosin L, et al. Does arterial recanalization improve outcome in carotid territory stroke? Stroke 1995;26:581-87
27. Kucinski T, Koch C, Eckert B, et al. Collateral circulation is an independent radiological predictor of outcome after thrombolysis in acute ischaemic stroke. Neuroradiology 2003;45:11-18
28. Caplan LR, Hennerici M. Impaired clearance of emboli (washout) is an important link between hypoperfusion, embolism, and ischemic stroke. Arch Neurol 1998;55:1475-82
29. Bisschops RH, Klijn CJ, Kappelle LJ, et al. Collateral flow and ischemic brain lesions in patients with unilateral carotid artery occlusion. Neurology 2003;60:1435-41
30. Wolpert SM, Bruckmann H, Greenlee R, et al. Neuroradiologic evaluation of patients with acute stroke treated with recombinant tissue plasminogen activator. The rt-PA Acute Stroke Study Group. AJNR Am J Neuroradiol 1993;14:3-13
31. Freitag HJ, Becker VU, Thie A, et al. Lys-plasminogen as an adjunct to local intra-arterial fibrinolysis for carotid territory stroke: laboratory and clinical findings. Neuroradiology 1996;38:181-85